Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioCryst seeks FDA go-ahead for T-cell leukemia trial
Fodosine, is a transition-state analog inhibitor of the target enzyme purine nucleoside phosphorylase (PNP). The drug is currently in a phase IIa trial for patients with T-cell leukemia
Fodosine, is a transition-state analog inhibitor of the target enzyme purine nucleoside phosphorylase (PNP). The drug is currently in a phase IIa trial for patients with T-cell leukemia
This is the first preclinical study in which the injected cells were autologous, meaning they came from the animals’ own tissue, were not cultured, so that they did
Pravastatin is marketed by Bristol-Myers Squibb in the US under the name Pravachol. The ruling in Teva’s favour is the second decision regarding this product that has been
The trials are being partially funded by The US Department of Defense and carried out in collaboration with the US Army Medical Research Institute of Infectious Diseases (USAMRIID).
Under the terms of the agreement, GE Healthcare will distribute the ThermoGenesis developed AXP AutoXpress platform upon launch in early 2006, as well as the BioArchive System. The
This is the first-ever phase II program for a small interfering RNA (siRNA) therapy, an innovative approach based on the powerful gene silencing technology of RNA interference (RNAi).
The study at the UK’s University of Manchester was a placebo-controlled trial on 378 patients with moderate to severe psoriasis, to test the efficacy and safety of the
The Committee for Medicinal Products for Human Use, a division of the European Medicines Agency, issued the positive opinion, which is likely to be acted upon by the
Pinnacle has acquired all of the issued and outstanding shares of Bioplus for 5,000,000 new treasury shares of Pinnacle. Bioplus is a pharmaceutical development company incorporated to develop,
Chiron was due to supply the American market with up to 50 million doses of its flu vaccine in the last influenza season, however contamination concerns found by